quant Healthcare Fund · Direct · Growth
NAV
₹19.2121
as of 17 Nov 2026
Expense Ratio
1.57%
Lumpsum returns (CAGR)
- 1Y
- +18.73%
- 3Y
- +19.98%
- 5Y
- —
- Since Inception
- +21.61%
SIP returns (XIRR)
- 1Y
- +28.62%
- 3Y
- +15.29%
- 5Y
- —
- Since Inception
- +16.50%
Performance Comparison
Sectoral allocation
as of 31 Oct 2026- Pharmaceuticals & Biotechnology55.22%
- Food Products4.50%
- Consumer Durables3.34%
- Personal Products3.18%
- Fertilizers & Agrochemicals0.19%
Each sector links to the mutual funds most exposed to it.
Thinking about quant Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with quant Healthcare Fund - Growth Option - Regular Plan
- 1Zydus Lifesciences Limited10.25%
- 2Aurobindo Pharma Limited9.83%
- 3Glaxosmithkline Pharmaceuticals Ltd8.89%
- 4Strides Pharma Science Limited8.79%
- 5Pfizer Ltd7.14%
- 6Ipca Laboratories Ltd5.37%
- 7Zydus Wellness Ltd4.50%
- 8Lg Electronics India Limited3.34%
- 9Colgate-Palmolive (India) Ltd3.18%
- 10Dr. Reddy'S Laboratories Limited2.61%
What this fund does
quant Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
quant Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by quant Mutual Fund. The fund has been operational for over 3 years. It benchmarks its performance against NIFTY HEALTHCARE INDEX TRI. The current expense ratio is 1.57%.